ALCOHOLIC LIVER DISEASE – NEW DATA ON THE EPIDEMIOLOGY AND PATHOGENESIS OF THE DISEASE
Main Article Content
Abstract
The aim of the research – to carry out an analytical review of modern sources of scientific literature, covering pathogenesis of alcoholic liver disease.
Materials and methods. The analysis of 55 domestic and foreign sources of literature on this topic.
Results. Based on the results of the analysis of scientific data, the understanding of the pathogenesis of alcoholic liver disease.
Conclusion. Alcoholic liver disease is associated with immediate and long-term fatal risks, which makes it an urgent problem. The analysis shows that this pathology requires further study.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Mathurin P, Hadengue A, Bataller R. EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. European Association for the Study of the Liver. J of Hepatology. 2012; 57: 399-420
Jürgen Rehm. The risks associated with alcohol use and alcoholism. Alcohol Res Health. 2011; 34(2): 135-143
Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014; 12: 145
Sheron N. Alcohol and liver disease in Europe: simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol. 2016; 64: 957-967
Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis. 2019; 23(1): 39-50
Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, et al. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol. 2017; 46: 827-839
Rehm J, Room R, Graham K, et al. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: An overview. Addiction. 2003; 98(9): 1209-1228
Mackenbach JP, Kulhánová I, Bopp M, Borrell C, Deboosere P, Kovács K et al. Inequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality Registers. PLoS Med. 2015; 12(12): e1001909
Indicator Code Book Global Information System on Alcohol and Health. WHO, 2016
Russian statistical yearbook. 2019: Statsb./Rosstat. P76 M., 2019; 708 p. Russian (Российский статистический ежегодник. 2019: Стат.сб./Росстат. Р76 М., 2019. 708 с.)
Stickel F, Datz C, Hampe J, Bataller R. Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017; 11(3): 447
2015-2020 Dietary Guidelines for Americans. In: 8th ed. U.S. Department of Health and Human Services and U.S. Department of Agriculture; 2015
WHO. Food based dietary guidelines. 2003
Patra J, Taylor B, Rehm J. Deaths associated with high-volume drinking of alcohol among adults in Canada in 2002: A need for primary care intervention? Contemporary Drug Problems. 2009; 36(2): 283-301
Shield KDR, Rehm, J. Public health successes and missed opportunities Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990–2014. In. WHO. Copenhagen, Denmark: WHO Regional Office for Europe; 2016
Becker U, Grønbaek M, Johansen D, et al. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology. 2002; 35: 868-875
Kennedy OJ, Roderick P, Buchanan R, et al. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016; 43: 562-574
Dam MK, Flensborg-Madsen T, Eliasen M et al. Smoking and risk of liver cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2013; 48: 585-591
Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol. 2014; 20: 11929-11934
Hart CL, Morrison DS, Batty GD, et al. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010; 340: c1240
Reed T, Page WF, Viken RJ, et al. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res. 1996; 20: 1528-1533
Eagon PK. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol. 2010; 16: 1377-1384
Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001; 25: 502-507
Moses VG. Hormonal contraception in women at risk for the development of arterial and venous thrombosis. Questions of gynecology, obstetrics and perinatology. 2009; 2: 83-87. Russian (Мозес В.Г. Гормональная контрацепция у женщин группы риска по развитию артериальных и венозных тромбозов //Вопросы гинекологии, акушерства и перинатологии. 2009. Т. 8, № 2. С. 83-87)
Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002; 123(4): 1044-1051
Buch S, Stickel F, Trépo E, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015; 47: 1443-1448
Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol. 2017; 66: 195-211
Rocco A, Compare D, Angrisani D. et al. Alcoholic disease: liver and beyond. World J Gastroenterol. 2014; 20(40): 14652-14659
Teschke R. Microsomal ethanol-oxidizing system (MEOS): Success over 50 years and an encouraging future. Alcohol Clin. Exp. Res. 2019; 43: 386-400
Teschke R., Zhu Y. Opinion: Intestinal microbiome, endotoxins, cytochrome P450 2E1, and the gut-liver axis in alcoholic liver disease. EC Gastroenterology Dig. Syst. 2019; 6: 66-75
Salaspuro M. Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury. Oxf. Textb. Clin. Hepatol. 1991; 2: 791-810
Pizon A.F., Becker C.E., Bikin D. The clinical variations in ethanol toxicokinetics. Toxicol Rev. 2007; 3: 63-72
Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): Cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin. Pharm. 2018; 19: 779-793
Parker R., Kim SJ., Gao B. Alcohol, adipose tissue and liver disease: Mechanistic links and clinical considerations. Nat. Rev. Gastroenterol. Hepatol. 2018; 15: 50-59
Cederbaum AI. Alcohol metabolism. Clin. Liver Dis. 2012; 16: 667-685
Geschke R., Hasumura Y., Joly J.G., et al. Microsomal ethanol-oxidizing system (MEOS): Purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem. Biophys. Res. Commun. 1972; 49: 1187-1193
Lieber CS., DeCarli LM. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: Enhanced by ethanol consumption. Science. 1970; 170: 78-80
Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol. 2009; 76(2): 215-228
Teschke R. Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance. Biomedicines. 2019; 7(3): 68
Lieber C.S. Alcohol and the liver: 1994 update. Gastroenterology. 1994; 106: 1085-1105
Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010; 29: 437-445
Osna NA, Donohue TM, Kharbanda KK. Alcoholic liver disease: Pathogenesis and current management. Alcohol Res. 2017; 38: 147-161
Neuman MG, French SW, Zakhari S, et al. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp. Mol. Pathol. 2017; 102: 162-180
Lieber CS, DeCarli LM, Matsuzaki S, Ohnishi K, Teschke R. The microsomal ethanol oxidizing system (MEOS). Methods Enzym. 1978; 52: 355-367
Brunt EM, Neuschwander-Tetri BA, Burt AD. Fatty liver disease: alcoholic and non-alcoholic. In: Burt A, Portmann B, Ferrell L, editors. MacSween’s pathology of the liver. 6th ed. Edinburgh: Churchill Livingstone, 2012. P. 293-360
Roh YS, Zhang B, Loomba R, Seki E. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol. 2015; 309: 30-41
An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012; 86: 1337-1348
Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013; 59: 155-201
Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut. 2015; 64: 1949-1960
Lanthier N, Rubbia-Brandt L, Lin-Marq N, et al. Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. J Hepatol. 2015; 63: 609-621
Sancho-Bru P, Altamirano J, Rodrigo-Torres D, et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology. 2012; 55: 1931-1941
Schuppan D. Liver fibrosis: common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol. 2015; 39: 51-59
Patsenker E, Stoll M, Millonig G, et al. Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med. 2011; 17: 1285-1294
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127: 35-50
Villanueva A, Portela A, Sayols S, et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 2015; 61: 1945-1956